Moreover, it has been shown that activation of the IL6 inflammatory loop in p53−PTEN− cancer cells is associated with reduced SOCS3 expression which serves as a negative regulator of IL6-mediated signaling, and forced expression of SOCS3 or using IL6-R blockade inhibited tumor proliferation and metastasis in mouse xenografts [92]. This evidence concerns the gene IL6 and cancer.